FDA ta amince da sabon magani don ƙwayar cuta

A yau, FDA ta Amurka ta sanar da amincewar SIGA Technologies 'sabon magani TPOXX (tecovirimat) don maganin ƙwayar cuta. Yana da kyau a faɗi cewa wannan shine sabon magani na 21 da hukumar FDA ta Amurka ta amince da ita a wannan shekara kuma sabon magani na farko da aka amince da shi don maganin ƙanƙara.

Sunan ƙananan ƙwayar cuta, masu karatu na masana'antar biomedical ba za su saba ba. Alurar rigakafin cutar sankarau ita ce rigakafin farko da mutane suka yi nasara, kuma muna da makamin rigakafin wannan cuta mai saurin kisa. Tun lokacin da aka yi allurar rigakafin cutar sankarau, mutane sun yi nasara a yaƙi da ƙwayoyin cuta. A shekara ta 1980, Hukumar Lafiya ta Duniya ta ba da sanarwar cewa mun kawar da barazanar ƙanƙara. Irin wannan cuta mai yaduwa da aka yi ta fama da ita kuma aka yi ta magana akai, sannu a hankali ta kau daga hakin mutane.

Amma da sarkakiyar yanayin kasa da kasa cikin wadannan shekarun da suka gabata, mutane sun fara nuna damuwa cewa za a iya mayar da kwayar cutar sankarau ta zama makamin halittu, wanda ke barazana ga rayuwar talakawa. Saboda haka, mutane kuma sun yanke shawarar samar da wani magani wanda zai iya magance ƙwayar cuta idan akwai gaggawa. TPOXX ya kasance. A matsayin maganin rigakafi, yana iya yin tasiri sosai akan yaduwar kwayar cutar variola a cikin jiki. Dangane da yuwuwar sa, wannan sabon magani an ba shi cancantar saurin tafiya, cancantar sake dubawa, da cancantar magungunan marayu.

An gwada inganci da amincin wannan sabon magani a gwajin dabbobi da na ɗan adam, bi da bi. A cikin gwaje-gwajen dabbobi, dabbobin da suka kamu da TPOXX sun rayu tsawon lokaci fiye da waɗanda aka yi musu magani tare da placebo bayan kamuwa da cutar ta variola. A cikin gwajin ɗan adam, masu binciken sun ɗauki 359 masu aikin sa kai masu lafiya (ba tare da kamuwa da cutar sankara ba) kuma sun nemi su yi amfani da TPOXX. Bincike ya nuna cewa illar da aka fi samu sun hada da ciwon kai, tashin zuciya, da ciwon ciki ba tare da wata illa mai tsanani ba. Dangane da ingancin da aka nuna a gwaje-gwajen dabba da amincin da gwajin ɗan adam ya nuna, FDA ta amince da ƙaddamar da sabon magani.

“Don mayar da martani game da haɗarin ta’addanci, Majalisa ta ɗauki matakai don tabbatar da cewa ana amfani da ƙwayoyin cuta a matsayin makamai, kuma mun ƙirƙira kuma mun amince da matakan kariya. Amincewar yau tana wakiltar babban ci gaba a cikin waɗannan ƙoƙarin!” Daraktan FDA Scott Gottlieb Likitan ya ce: “Wannan ita ce sabuwar magani ta farko da za a ba da fifikon fifikon 'Material Threat Medical Countermeasure'. Amincewar yau kuma tana nuna ƙudirin FDA don tabbatar da cewa mun shirya don rikicin lafiyar jama'a da samar da tsaro akan lokaci. Sabbin samfuran magunguna masu inganci.”

Ko da yake ana sa ran wannan sabon maganin zai yi maganin cutar sankarau, amma muna sa ran cewa cutar ba za ta sake dawowa ba, kuma muna sa ran ranar da ’yan Adam ba za su taɓa yin amfani da wannan sabon magani ba.